Yamada, H.; Okamoto, M.; Nagasaki, Y.; Yoshio, S.; Nouno, T.; Yano, C.; Tanaka, T.; Watanabe, F.; Shibata, N.; Arimizu, Y.;
et al. Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19). Diagnostics 2022, 12, 339.
https://doi.org/10.3390/diagnostics12020339
AMA Style
Yamada H, Okamoto M, Nagasaki Y, Yoshio S, Nouno T, Yano C, Tanaka T, Watanabe F, Shibata N, Arimizu Y,
et al. Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19). Diagnostics. 2022; 12(2):339.
https://doi.org/10.3390/diagnostics12020339
Chicago/Turabian Style
Yamada, Hiroyoshi, Masaki Okamoto, Yoji Nagasaki, Suzuyo Yoshio, Takashi Nouno, Chiyo Yano, Tomohiro Tanaka, Fumi Watanabe, Natsuko Shibata, Yoko Arimizu,
and et al. 2022. "Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19)" Diagnostics 12, no. 2: 339.
https://doi.org/10.3390/diagnostics12020339
APA Style
Yamada, H., Okamoto, M., Nagasaki, Y., Yoshio, S., Nouno, T., Yano, C., Tanaka, T., Watanabe, F., Shibata, N., Arimizu, Y., Fukamachi, Y., Zaizen, Y., Hamada, N., Kawaguchi, A., Hoshino, T., & Morita, S.
(2022). Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19). Diagnostics, 12(2), 339.
https://doi.org/10.3390/diagnostics12020339
